I-DMAA Tablet CAS:2044-64-6

Amaphilisi e-DMAA avame ukudayiswa njengezithasiselo zangaphambi kokuzivocavoca, ethembisa amazinga aphezulu amandla kanye nokucaca kwengqondo ngesikhathi sokuzivocavoca. Athandwa kakhulu ngabakhi bomzimba kanye nabadlali abafuna ithuba lokusebenza kahle. Kodwa-ke, ukuphepha kwawo kusalokhu kuyinkinga ngenxa yezingozi ezingaba khona zenhliziyo nemithambo yegazi. I-US Food & Drug Administration (FDA) ixwayise abathengi ngezingozi ezingaba khona ezihlobene nemikhiqizo ye-DMAA, ithi ingase ibe yingozi empilweni yomphakathi. I-FDA ikhiphe izixwayiso ngezinkampani eziningana ezithengisa imikhiqizo equkethe i-DMAA. Kubalulekile ukuthi abathengi baqaphele lezi zingozi ngaphambi kokusebenzisa noma yimuphi umkhiqizo oqukethe i-DMAA. Naphezu kodumo lwayo oluphikisanayo, abanye abasebenzisi babika okuhlangenwe nakho okuhle ngamaphilisi e-DMAA maqondana nokuqina kokuzivocavoca okuthuthukisiwe kanye nokugxila ngesikhathi semisebenzi yomzimba. Njenganoma yisiphi isidakamizwa, ukusabela komuntu ngamunye kungahluka kakhulu kuye ngezici ezifana nobudala, izakhi zofuzo, umlando wezokwelapha njll., ngakho-ke kubalulekile ukubonisana nochwepheshe bezokwelapha ngaphambi kokusebenzisa noma yisiphi isithasiselo esiqukethe le nhlanganisela ikakhulukazi uma kukhona isimo senhliziyo esivele sikhona noma ezinye izinkinga zempilo. Ngamafuphi, ngenkathi inikeza izinzuzo zesikhashana zamazinga aphezulu amandla kanye nokuqapha, imiphumela yesikhathi eside yokusetshenziswa njalo noma ukudlula ngokweqile idinga ukucatshangelwa okungathi sína ngenxa yezinkinga zokuphepha ezihambisana nokusetshenziswa kwayo.